Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol and Botulinum Toxin for Essential Vocal Tremor
NCT02111369Phase 4Completed
- Sponsor
- Emory University
- Start
- May 2014
- Primary completion
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of propranolol, botulinum toxin type A in essential tremor (ET), sponsored by Emory University. Started May 2014; status: completed.
02
Drugs
propranololbotulinum toxin type A
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT02111369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02111369.